$KPTI Karyopharm Therapeutics Inc. Insider Trading Week 10/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. in week 10/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 09 2020 | KPTI | Karyopharm Therape ... | Paulson Richard A. | Director | Option Exercise | A | 26.12 | 50,000 | 1,306,000 | 50,000 |